The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Ligands for Glutamate Receptors: Design and Therapeutic Prospects
Open accessAbstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTLigands for Glutamate Receptors: Design and Therapeutic ProspectsHans Bräuner-Osborne, Jan Egebjerg, Elsebet Ø. Nielsen, Ulf Madsen, and Povl Krogsgaard-LarsenView Author Information NeuroScience PharmaBiotec Research Center, Department of Medicinal Chemistry, The Royal Danish School of Pharmacy, DK-2100 Copenhagen, Denmark, Department for Molecular and Structural Biology, University of Aarhus, DK-8000 Aarhus, Denmark, and Department of Neurochemistry, NeuroSearch A/S, DK-2750 Ballerup, Denmark Cite this: J. Med. Chem. 2000, 43, 14, 2609–2645Publication Date (Web):July 13, 2000Publication History Received5 January 2000Published online13 July 2000Published inissue 1 July 2000https://pubs.acs.org/doi/10.1021/jm000007rhttps://doi.org/10.1021/jm000007rreview-articleACS PublicationsCopyright © 2000 American Chemical SocietyRequest reuse permissionsArticle Views2557Altmetric-Citations469LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Agonists,Antagonists,Monomers,Peptides and proteins,Receptors Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–253 of 253
The Ionotropic Glutamate Receptors
Monaghan, D. T., & Wenthold, R. J. (1997) · The Receptors · doi:10.1007/978-1-4612-3962-8 · Cited by 76
CD14 and Immune Response to Lipopolysaccharide
Maliszewski, C. R. (1991) · Science · doi:10.1126/science.1718034 · Cited by 74
An analysis of philanthotoxin block for recombinant rat GluR6(Q) glutamate receptor channels
Bähring, R., & Mayer, M. L. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.635bm.x · Cited by 72
Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs
Ghauri, M., Chapman, A. G., & Meldrum, B. S. (1996) · Neuroreport · doi:10.1097/00001756-199606170-00005 · Cited by 71
The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus
Vignes, M., Bleakman, D., Lodge, D., & Collingridge, G. L. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00158-5 · Cited by 68
Lampinen, M., Pentikäinen, O. T., Johnson, M. S., & Keinänen, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4704 · Cited by 66
Transgenic animals relevant to Alzheimer’s disease
Seabrook, G. R., & Rosahl, T. W. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00170-1 · Cited by 63
Thomsen, C., Hansen, L., & Suzdak, P. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062038.x · Cited by 62
Ishida, M., & Shinozaki, H. (1988) · Brain Research · doi:10.1016/0006-8993(88)90456-8 · Cited by 61
Hawkins, L. M., Beaver, K. M., Jane, D. E., Taylor, P. M., Sunter, D. C., & Roberts, P. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16408.x · Cited by 60
Everts, I., Petroski, R. E., Kizelsztein, P., Teichberg, V. I., Heinemann, S. F., & Hollmann, M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-03-00916.1999 · Cited by 59
Procter, M., Houghton, A. K., Faber, E. S. L., Chizh, B. A., Ornstein, P. L., Lodge, D., & Headley, P. M. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00136-1 · Cited by 58
Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA
Stensbøl, T. B., Borre, L., Johansen, T. N., Egebjerg, J., Madsen, U., Ebert, B., & Krogsgaard‐Larsen, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00512-9 · Cited by 57
Self-citationCorasaniti, M. T., Melino, G., Navarra, M., Garaci, E., Finazzi‐Agrò, A., & Nistico, G. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90021-7 · Cited by 56
Hermans, E., Nahorski, S. R., & Challiss, R. A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00132-4 · Cited by 55
Jullian, N., Brabet, I., Pin, J., & Acher, F. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980571q · Cited by 52
Altered Hippocampal Kainate-Receptor mRNA Levels in Temporal Lobe Epilepsy Patients
Mathern, G. W., Pretorius, J. K., Kornblum, H. I., Mendoza, D., Lozada, A., Leite, J. P., Chimelli, L. M. C., Born, D. E., Fried, I., Sakamoto, A. C., et al. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0200 · Cited by 51
Löscher, W., Lehmann, H., Behl, B., Seemann, D., Teschendorf, H. J., Hofmann, H. P., Lubisch, W., Höger, T., Lemaire, H.-G., & Groß, G. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00432.x · Cited by 51
LY339434, a GluR5 kainate receptor agonist
Small, B. G., Thomas, J. W., Kemp, M., Hoo, K. H., Ballyk, B. A., Deverill, M., Ogden, A. M. L., Rubio, A., Pedregal, C., & Bleakman, D. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00122-1 · Cited by 50
Pellicciari, R., Costantino, G., Giovagnoni, E., Mattoli, L., Brabet, I., & Pin, J. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00265-0 · Cited by 50
Prospects of glutamate antagonists in the therapy of Parkinson's disease
Blandini, F., & Greenamyre, J. T. (1998) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1998.tb00918.x · Cited by 49
Shinozaki, H., Ishida, M., Shimamoto, K., & Ohfune, Y. (1989) · Brain Research · doi:10.1016/0006-8993(89)90207-2 · Cited by 48
Plasma amino acid levels in patients with amyotrophic lateral sclerosis
Iwasaki, Y., Ikeda, K., & Kinoshita, M. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90292-s · Cited by 47
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist
Baron, B. M., Harrison, B. L., Kehne, J. H., Schmidt, C. J., van Giersbergen, P. L. M., White, H. S., Siegel, B. W., Senyah, Y., McCloskey, T. C., Fadayel, G. M., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00045-9 · Cited by 47
Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington's disease
Murman, D. L., Giordani, B., Mellow, A. M., Johanns, J. R., Little, R. J. A., Hariharan, M., & Foster, N. L. (1997) · Neurology · doi:10.1212/wnl.49.1.153 · Cited by 46
Xenopus Oocytes express a unitary glutamate receptor endogenously
Soloviev, M., & Barnard, E. A. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1272 · Cited by 44
Kotlinska, J. H., & Liljequist, S. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00565-0 · Cited by 43
Synthesis and Enantiopharmacology of New AMPA-Kainate Receptor Agonists
Conti, P., Amici, M. D., Sarro, G. D., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991081g · Cited by 41
Donevan, S. D., & Rogawski, M. A. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00109-2 · Cited by 39
Krogsgaard‐Larsen, P., Nielsen, E. Ø., & Curtis, D. R. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00371a005 · Cited by 38
Self-citationFluoxetine in Parkinson's disease
Simons, J. A. (1996) · Movement Disorders · doi:10.1002/mds.870110517 · Cited by 38
Metabotropic Glutamate Receptors and Brain Function
Moroni, F., Nicoletti, F., & Pellegrini-Giampietro, D. E. (1998) · Florence Research (University of Florence) · Cited by 34
M�ller, E. H., Egebjerg, J., Brehm, L., Stensb�l, T. B., Johansen, T. N., Madsen, U., & Krogsgaard‐Larsen, P. (1999) · Chirality · doi:10.1002/(sici)1520-636x(1999)11:10<752::aid-chir3>3.0.co;2-t · Cited by 31
Self-citationACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats
Kretschmer, B. D., Kratzer, U., Breithecker, K., & Koch, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01047-9 · Cited by 31
Escribano, A., Ezquerra, J., Pedregal, C., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00091-2 · Cited by 31
Bräuner‐Osborne, H., Nielsen, B., Stensbøl, T. B., Johansen, T. N., Skjærbæk, N., & Krogsgaard-Larsen, P. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01263-6 · Cited by 30
Self-citationExcitatory Amino Acid Receptors. Design of Agonists and Antagonists
Tricklebank, M. D. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb05654.x · Cited by 30
Araki, T., Kogure, K., & Nishioka, K. (1990) · Research in Experimental Medicine · doi:10.1007/pl00020002 · Cited by 30
Tones, M. A., Bendali, N., Flor, P. J., Knöpfel, T., & Kühn, R. (1995) · Neuroreport · doi:10.1097/00001756-199512000-00028 · Cited by 29
The role of Arg78 in the metabotropic glutamate receptor mGlu1 for agonist binding and selectivity
Jensen, A. A., Sheppard, P. O., O’Hara, P. J., Krogsgaard‐Larsen, P., & Bräuner‐Osborne, H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00283-1 · Cited by 28
Self-citationInteraction of CPCCOEt with a chimeric mGlu1b and calcium sensing receptor
Bräuner‐Osborne, H., Jensen, A. A., & Krogsgaard‐Larsen, P. (1999) · Neuroreport · doi:10.1097/00001756-199912160-00036 · Cited by 27
Self-citationBowie, D., & Smart, T. G. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13642.x · Cited by 27
Tűckmantel, W., Kozikowski, A., Wang, S.-M., Pshenichkin, S., & Wroblewski, J. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)00068-1 · Cited by 25
Arnt, J., Sánchez, C., Lenz, S. M., Madsen, U., & Krogsgaard-Larsen, P. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00422-h · Cited by 24
Self-citationGlennon, R. A., Titeler, M., Lyon, R. A., & Slusher, R. M. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00399a031 · Cited by 23
Hunter, C., & Wenthold, R. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11353.x · Cited by 22
Glutamate Antagonists in Amyotrophic Lateral Sclerosis: A Review of Their Therapeutic Potential
Plaitakis, A., Fesdjian, C. O., & Shashidharan, P. (1996) · CNS Drugs · doi:10.2165/00023210-199605060-00004 · Cited by 20
Thomas, N. K., Hawkins, L. M., Miller, J. C., Troop, H. M., Roberts, P., & Jane, D. E. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00124-5 · Cited by 20
Umemura, K., Kondo, K., Ikeda, Y., Teraya, Y., Yoshida, H., Homma, M., Uematsu, T., & Nakashima, M. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04359.x · Cited by 19
Stensbøl, T. B., Sløk, F. A., Trometer, J. D., Hurt, S. D., Ebert, B., Kjøller, C., Egebjerg, J., Madsen, U., Diemer, N. H., & Krogsgaard‐Larsen, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00269-1 · Cited by 14
Self-citationHawkinson, J. E., & Espitia, S. A. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)89182-0 · Cited by 11
New analogues of ACPD with selective activity for group II metabotropic glutamate receptors.
Bräuner-Osborne, H., Madsen, U., Mikiciuk-Olasik, E., & Curry, K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01098-4 · Cited by 8
Self-citationEugène, D., Moss, S. J., & Smart, T. G. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01342.x · Cited by 7
Cited by
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Glutamate receptor function in learning and memory
Riedel, G. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00272-3 · Cited by 962
Mechanisms for Activation and Antagonism of an AMPA-Sensitive Glutamate Receptor
Armstrong, N., & Gouaux, E. (2000) · Neuron · doi:10.1016/s0896-6273(00)00094-5 · Cited by 872
Metadata
- Authors
- Bräuner-Osborne, H., Egebjerg, J., Nielsen, E. Ø., Madsen, U., & Krogsgaard-Larsen, P.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-07-01
- Volume
- 43
- Issue
- 14
- Pages
- 2609-2645
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1989363688
- Cited by
- 524
- References
- 253
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.